Immunology

A new approach to cell engineering could make off-the-shelf CAR T cell therapies a reality.

A groundbreaking fusion of flow cytometry and cell imaging pushes the limits of cell examination and sorting. 

Microbiome researcher Sarah Lebeer studies how beneficial bacteria can help treat inflammatory skin conditions such as acne and atopic dermatitis.

Researchers use cell-free DNA circulating in the blood of patients with rheumatoid arthritis to match them with the most effective drugs. 

T cells have long held the title of the ideal immune cells for CAR therapy, but recent discoveries are opening new possibilities for other immune cells.

Pain research has traditionally relied on animal models. Theodore Price studies human tissues to better understand pain disorders across age and sex.

Single amino acid changes in healthy hematopoietic stem cells may lead to safer treatments for acute myeloid leukemia.

Many of the same therapies used to activate the immune system against cancer may also combat infectious diseases.

Viral diseases like hepatitis don’t have many successful treatments available, so scientists are engineering antibodies to try and change that.

Highly potent antibody candidates isolated via advanced flow cytometry is growing the list of approved therapeutic antibodies.

Researchers use mRNA to create cancer vaccines that are personalized to each individual’s unique tumor.

Researchers mix gene editing with the principles of martial arts to boost T cell therapies.